Stock KALY KALI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Kali, Inc. Stock

Equities

KALY

US4833801016

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 02:09:30 2024-04-18 pm EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Kali, Inc. 0.00% 0.00%
2020 PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. CI
2020 PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. CI

Financials (USD)

Sales 2011 88.83M Sales 2012 94.55M Capitalization 9.63M
Net income 2011 13M Net income 2012 17M EV / Sales 2011 0.24 x
Net cash position 2011 14.72M Net cash position 2012 26.92M EV / Sales 2012 -0.18 x
P/E ratio 2011
2.66 x
P/E ratio 2012
0.55 x
Employees 171
Yield 2011 *
-
Yield 2012
-
Free-Float 98.86%
More Fundamentals * Assessed data

Chart Kali, Inc.

Dynamic Chart

Latest news about Kali, Inc.

PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. CI
PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. CI
Puration, Inc. completed the acquisition of Hemp4mula CBD Confections operations of Kali, Inc.. CI
Kali-Extracts, Inc. Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment CI
Puration, Inc. made a proposal to acquire Hemp4mula CBD Confections operations of Kali, Inc.. CI
Kali, Inc. announced that it expects to receive $20 million in funding CI
KALY Enters into Discussions with Puration Regarding Pura's Possible Acquisition of KALY's CBD Confection Assets CI
Kali-Extracts, Inc. Reports Sales Results for the Three Months and Year to Date Ended September 30, 2019; Provides Sales Guidance for the Year 2019 CI
Kali-Extracts, Inc. Announces Plans to Introduce USDA Organic CBD Oil and USDA Organic CBD Infused Beverages CI
Kali-Extracts Announces Third CBD Extraction Agreement Adding to $15 Million in Current Contracts CI
Kali Extracts Announces USDA Organic Certification for First Hemp Crop CI
Kali-Extracts, Inc. Announces New CBD Hemp4mula Gummies Now Available on USMJ.com CI
Kali-Extracts Is Making CBD Infused Coffee CI
Kali-Extracts, Inc. Releases an Update on the Cannabis Extract Biopharmaceutical Developments CI
Kali-Extracts, Inc. Provides Revenue Guidance for the Fourth Quarter of 2019 CI
More news

Press releases Kali, Inc.

Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand AQ
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs AQ
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End AQ
Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment AQ
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research NE
More press releases

Highs and lows

1 month
0.00
Extreme 0
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.02
10 years
0.00
Extreme 0
0.85
More quotes

Managers and Directors - Kali, Inc.

Managers TitleAgeSince
Frederick Ferri CEO
 Chief Executive Officer - 18-12-18
More insiders

Quotes

Date Price Change Volume

Delayed Quote OTC Markets, April 18, 2024 at 02:09 pm EDT

More quotes

Company Profile

Kali, Inc. is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.
Sector
Pharmaceuticals
More about the company

Sector Other Pharmaceuticals

1st Jan change Capi.
KALI, INC. Stock Kali, Inc.
0.00% 1.54K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 660B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+22.69% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.27% 219B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 196B
NOVARTIS AG Stock Novartis AG
+6.49% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KALY Stock